Talatisamine (BioDeep_00000184121)

Main id: BioDeep_00000000196

 

human metabolite PANOMIX_OTCML-2023 blood metabolite


代谢物信息卡片


11-ethyl-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol

化学式: C24H39NO5 (421.2828084)
中文名称: 塔拉萨敏
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)OC)COC
InChI: InChI=1S/C24H39NO5/c1-5-25-11-22(12-28-2)7-6-18(30-4)24-14-8-13-16(29-3)10-23(27,19(14)20(13)26)15(21(24)25)9-17(22)24/h13-21,26-27H,5-12H2,1-4H3

描述信息

Talatisamine, a aconitum alkaloid, is specific K+ channel blocker. Talatisamine attenuates beta-amyloid oligomers induced neurotoxicity in cultured cortical neurons[1].
Talatisamine, a aconitum alkaloid, is specific K+ channel blocker. Talatisamine attenuates beta-amyloid oligomers induced neurotoxicity in cultured cortical neurons[1].

同义名列表

2 个代谢物同义名

11-ethyl-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol; Talatisamine



数据库引用编号

4 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Shuai Huang, Yang Lv, Jian-Zhu Wang, Mei-Zhen Ye, Rui-Jie Lu, Lin Chen, Jiang Xie, Feng Gao, Xian-Li Zhou. Metabolite Profiling of Talatisamine in Heart Tissue After Oral Administration and Analysis of Cardiac Bioactivities. Planta medica. 2023 Jan; ?(?):. doi: 10.1055/a-1956-7542. [PMID: 36202094]
  • Mengchun Chen, Yijie Chen, Xianqin Wang, Yunfang Zhou. Quantitative determination of talatisamine and its pharmacokinetics and bioavailability in mouse plasma by UPLC-MS/MS. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2019 Aug; 1124(?):180-187. doi: 10.1016/j.jchromb.2019.06.015. [PMID: 31207562]
  • Ahmatbeck Samanbay, Bo Zhao, Haji Akber Aisa. A new denudatine type C20-diterpenoid alkaloid from Aconitum sinchiangense W. T. Wang. Natural product research. 2018 Oct; 32(19):2319-2324. doi: 10.1080/14786419.2017.1410814. [PMID: 29212360]
  • Zhi-jun Guo, Zhu-ya Yang, Wen-hong Tan, Zhi-hong Zhou, Xiao-xia Ma. [Chemical Constituents from Processed Products of Aconitum Vilmoriniani Radix]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials. 2015 May; 38(5):988-91. doi: . [PMID: 26767293]
  • Feng Gao, Qiao-Hong Chen, Feng-Peng Wang. C19-diterpenoid alkaloids from Aconitum hemsleyanum var. circinatum. Journal of natural products. 2007 May; 70(5):876-9. doi: 10.1021/np0700117. [PMID: 17432903]
  • Le Cai, Dong-Lin Chen, Shuang-Yong Liu, Feng-Peng Wang. New C19-diterpenoid alkaloids from Aconitum piepunense. Chemical & pharmaceutical bulletin. 2006 Jun; 54(6):779-81. doi: 10.1248/cpb.54.779. [PMID: 16755043]
  • Shan-Hao Jiang, Pei-Ming Yang, Hui Zhou, Da-Yuan Zhu. Two norditerpenoid ester alkaloids from Aconitum bulleyanum. Planta medica. 2002 Dec; 68(12):1147-9. doi: 10.1055/s-2002-36359. [PMID: 12494351]